Outcome of Patients With Acute Myeloid Leukemias or Myelodysplastic Syndromes After Relapsing From Allogeneic Stem Cell Transplantation: The GITMO AML/MDS-Relapse Registry Study

Am J Hematol. 2025 Oct;100(10):1902-1905. doi: 10.1002/ajh.70030. Epub 2025 Aug 6.
No abstract available

Keywords: acute myeloid leukemia; allogeneic stem cell tansplantation; disease burden; myelodysplastic syndrome; relapse.

Publication types

  • Letter